VIOLIN Logo
Virmugen Banner
Search: for Help
Virmugen Home
Introduction
Statistics
News and Updates
Virmugen Query
Virmugen Blast
Data Submission
Data Exchange
Data Download
Documentation
FAQs
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaccine Comparison

Escherichia coli carAB mutant vaccine Escherichia coli ler mutant vaccine Escherichia coli rfaL mutant vaccine
Vaccine Information Vaccine Information Vaccine Information
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Turkey
  • carA gene engineering:
    • Type: Gene mutation
    • Description: This carAB mutant is from Escherichia coli (Kwaga et al., 1994).
    • Detailed Gene Information: Click Here.
  • carB gene engineering:
    • Type: Gene mutation
    • Description: This carAB mutant is from Escherichia coli (Kwaga et al., 1994).
    • Detailed Gene Information: Click Here.
  • Immunization Route: Oral immunization
  • Vaccine Ontology ID: VO_0002838
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • ler gene engineering:
    • Type: Gene mutation
    • Description: This ler mutant is from Escherichia coli (Liu et al., 2009).
    • Detailed Gene Information: Click Here.
  • ler gene engineering:
    • Type: Gene mutation
    • Description: This ler mutant is from Escherichia coli (Liu et al., 2009).
    • Detailed Gene Information: Click Here.
  • Immunization Route: Oral immunization
  • Vaccine Ontology ID: VO_0002839
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • rfaL gene engineering:
    • Type: Gene mutation
    • Description: This mutant is from Escherichia coli (Billips et al., 2009).
    • Detailed Gene Information: Click Here.
  • Immunization Route: Bladder instillation
References References References
Kwaga et al., 1994: Kwaga JK, Allan BJ, van der Hurk JV, Seida H, Potter AA. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys. Infection and immunity. 1994; 62(9); 3766-3772. [PubMed: 8063392].
Liu et al., 2009: Liu J, Sun Y, Feng S, Zhu L, Guo X, Qi C. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins. Vaccine. 2009; 27(43); 5929-5935. [PubMed: 19682616].
Billips et al., 2009: Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. The Journal of infectious diseases. 2009; 200(2); 263-272. [PubMed: 19522648].